Thinking About Investing in Bath & Body Works (BBWI)? Know This!

Shares of Consumer Cyclical sector company Bath & Body Works moved 1.6% today, and are now trading at a price of $32.04. The mid-cap stock's daily volume was 272,074 compared to its average volume of 3,322,945. The S&P 500 index returned a -0.0% performance.

Bath & Body Works, Inc. operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company is based in Columbus and has 8,800 full time employees. Its market capitalization is $7,285,287,424. Bath & Body Works currently offers its equity investors a dividend that yields 2.5% per year.

18 analysts are following Bath & Body Works and have set target prices ranging from $37.0 to $68.0 per share. On average, they have given the company a rating of buy. At today's prices, BBWI is trading -32.94% away from its average analyst target price of $47.78 per share.

Over the last year, BBWI's share price has increased by 5.0%, which represents a difference of -13.0% when compared to the S&P 500. The stock's 52 week high is $49.55 per share whereas its 52 week low is $27.3. With average free cash flows of $1.01 Billion that have been growing at an average rate of 2.6% over the last 6 years, Bath & Body Works is in a position to continue its strong stock performance trend.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 1,144,000 328,000 816,000 -33.22
2022 1,492,000 270,000 1,222,000 -32.52
2021 2,039,000 228,000 1,811,000 132.78
2020 1,236,000 458,000 778,000 4.01
2019 1,377,000 629,000 748,000 7.01
2018 1,406,000 707,000 699,000
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.